Correction to: Cell Death and Differentiation (2015) 22, 549–559; doi:10.1038/cdd.2015.3; published online 6 February 2015
Additional information
The online version of the original article can be found at 10.1038/cdd.2015.3
Rights and permissions
About this article
Cite this article
Peter, M., Hadji, A., Murmann, A. et al. Erratum: The role of CD95 and CD95 ligand in cancer. Cell Death Differ 22, 885–886 (2015). https://doi.org/10.1038/cdd.2015.25
Published:
Issue Date:
DOI: https://doi.org/10.1038/cdd.2015.25
This article is cited by
-
Ketoprofen suppresses triple negative breast cancer cell growth by inducing apoptosis and inhibiting autophagy
Molecular Biology Reports (2023)
-
The mechanism of how CD95/Fas activates the Type I IFN/STAT1 axis, driving cancer stemness in breast cancer
Scientific Reports (2020)
-
Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3
Scientific Reports (2020)
-
Engineering universal cells that evade immune detection
Nature Reviews Immunology (2019)
-
Magnetic nanoparticle-mediated gene therapy to induce Fas apoptosis pathway in breast cancer
Cancer Gene Therapy (2018)